Combination of growth factor gene-enhanced cartilage matrix synthesis with interleukin-1 receptor antagonist protein (IL1Ra) abrogation of cartilage matrix degradation may reduce and possibly reverse cartilage loss in synovitis and osteoarthritis. The feasibility of cotransduction of synovial membrane with two such genes that may act on cartilage homeostasis was investigated in an in vitro coculture system. Cultured synoviocytes in monolayer were cotransduced with E1-deleted adenoviral vectors, one containing IGF-I coding sequence under cytomegalovirus (CMV) promoter control (200 multiplicities of infection (moi)), and the second containing IL-1Ra sequence under CMV promoter control (100 moi). Adenovirus-IGF-I (AdIGF-I) transduction and AdIGF-I/AdIL1Ra cotransduction of synovial monolayer cultures resulted in increased IGF-I mRNA and ligand expression, and similarly AdIL-1Ra and AdIGF-I/AdIL-1Ra-transduced cultures expressed high levels of IL-1Ra. Northern analysis confirmed a single mRNA transcript of the appropriate size for both IGF-I and IL-1Ra transgene expression. Synovial cell monolayer and cartilage explant coculture experiments were used to examine the effects of IGF-I and IL-1Ra protein expressed by transduced synoviocytes on normal and IL-1-depleted cartilage. Transduced monolayer cultures produced peak medium IGF-I content of 114720.2 ng/ml and IL-1Ra levels of 241.8710.5 ng/ml at 48 h after transduction. These IGF-I concentrations were sufficient to produce significantly increased proteoglycan (PG) content of normal cartilage cultured in medium conditioned by AdIGF-I and AdIGF-I/ AdIL-1Ra-transduced synoviocytes. Interleukin-1-exposed cartilage was markedly depleted of PG, and this catabolic state was partially reversed in AdIGF-I-transduced cultures and fully reversed by AdIGF-I/AdIL-1Ra-transduced synovial cocultures. These data indicate that cultured synoviocytes are readily cotransduced by two recombinant adenoviral vectors containing transgenes active in restoring joint health. The AdIL-1Ra and AdIGF-I transgenes were abundantly expressed and the secreted products achieved therapeutic concentrations by day 2. The resulting increase in matrix biosynthesis returned cartilage PG content to normal levels. These data suggest that there may be significant value in cotransduction of synovial membrane to attenuate cartilage malacia associated with synovitis, injury, or early arthritis.
Introduction
Cartilage health depends on a delicate balance between cartilage matrix synthesis and degradation, and is largely a function of the interplay of anabolic growth factors such as IGF-I and catabolic agents, particularly Interleukin-1 (IL-1). Catabolism predominates in disease conditions such as synovitis and osteoarthritis, and matrix deterioration and physical disruption soon follow. From a therapeutic standpoint, IGF-I promotes cartilage healing when administered intra-articularly, 1 but the residence time is limited to several days. 2 Delivery of IGF-I by gene transduction of the synovial structures would be a less invasive and more persistent means of supplying growth factors. 3 Abrogation of the catabolic axis through antagonism of IL-1 would further add to the restoration of cartilage integrity, [4] [5] [6] [7] [8] and combination of IL-1 receptor antagonist protein (IL-1Ra) and IGF-I in the same gene construct, or given concurrently in standalone gene constructs, may provide dual axis therapy that can aid in cartilage resurfacing procedures and attenuate arthritic processes.
Chondrocytes are not ideal targets for gene therapy in situ because of their protected position in the cartilaginous matrix and their relatively low proliferative and biosynthetic rates. By contrast, the synovial lining presents a large array of cellular targets for gene therapy, which are in close proximity to the articular surface, and communicate with it via synovial fluid. Furthermore, synovial lining cells are comparatively less likely to express viral proteins on their surfaces, thus making them less susceptible to an immune response than other cell types following infection. 9 In this study, we investigated adenovirus cotransduction of synovial lining cells with IGF-I and IL-1Ra, working on the hypothesis that coordinate increases in IGF-I and IL1Ra proteins would aid in the restoration of depleted cartilage without deleterious effects on the architecture or function of the synovium.
Results
Synovial monolayer culture AdIGF-I and AdIL-1Ra transgene expression. Viralmediated IGF-I and IL-1Ra transgene activity in monolayers was confirmed by Northern blot, with IGF-I and IL-1Ra transcript bands of appropriate size ( Figure 1a) . Stromelysin (MMP-3, metalloproteinase-3) expression was elevated in all synovial cultures transduced by adenovirus constructs (Figure 1a ). There was no apparent differences in stromelysin expression between the synoviocytes transduced by various transgenes, or those exposed to both IGF-I and IL-1Ra transgenes ( Figure 1b ). Cell monolayers cotransduced with both AdIGF-I and AdIL-1Ra showed abundant expression of both transgenes on Northern analysis. The size of the mRNA bands on Northern blot was used to verify the IGF-I and IL-1Ra message response was transgene induced rather than constitutive mRNA expression. Untransduced control synoviocyte cultures had no evidence of IGF-I or IL-1Ra mRNA expression (Figure 1a ). There were no morphologic signs of toxicity such as nuclear pycnosis or cell membrane disruption in the synoviocyte cultures.
IGF-I and IL-1Ra synthesis. Medium IGF-I was significantly elevated in all monolayer cultures transduced with AdIGF-I or cotransduced with AdIGF-I/ AdIL-1Ra (Table 1) . Peak IGF-I synthesis was evident on day 4 of culture, and IGF-I content tended to decline by day 6. Similarly, medium IL-1Ra concentrations were significantly elevated in AdIL-1Ra and AdIGF/IL-1Ra-coinfected synovial monolayers (Table 2) . However, peak IL-1Ra concentrations were evident by day 2, with a marked decline by day 4 and 6. There was no significant difference in IL-1Ra levels between AdIL-1Ra or AdIGF-I/AdIL-1Ra-cotransduced cultures.
Synoviocyte cytokine and matrix molecule gene expression. The effects of AdIGF-I and AdIL-1Ra on the synovium were analyzed using real-time RT-PCR analysis of IL-1a, IL-1b, MMP-13, collagen type I, and decorin gene expression. Interleukin-1a and IL-1b mRNA levels followed similar trends in cocultures containing normal cartilage and in cultures containing IL-1-conditioned cartilage. Synoviocytes infected with AdIGF-1 had reduced IL-1a and IL-1b expression ( Figure 2 ). Conversely, AdIL-1Ra increased IL-1a expres- Gene-mediated restoration of IL-1-depleted cartilage AJ Nixon et al sion in synoviocyte cultures to a minor extent, and AdIL1Ra significantly increased IL-1b expression ( Figure 2 ). MMP-13 expression was significantly reduced by both AdIGF-I, AdIL-1Ra, and AdIGF-I/AdIL-1Ra infection of synoviocytes ( Figure 3 ). Synovial monolayer collagen type I expression was significantly decreased in AdIGF-I, AdIL-1Ra, and AdIGF-I/AdIL-1Ra-cotransduced synoviocyte cultures (Figure 4a ). Coculture with IL-1-depleted cartilage reduced collagen type I expression in untransduced synoviocytes, and the effects of AdIGF-I and AdIL-1Ra transduction were less apparent (Figure 4a ). Decorin gene expression was significantly decreased in monolayers cocultured with IL-1-depleted cartilage and dually transduced with AdIGF-I and AdIL-1Ra (Figure 4b ).
Synoviocyte/cartilage coculture
Coculture of transduced synovial monolayers with normal cartilage showed AdIGF-I and AdIGF-I/AdIL1Ra expressing synoviocytes increased explant proteoglycan (PG) content above uninfected control levels ( Figure 5a ). Paradoxically, medium from AdIL-1Ra-transduced synoviocytes induced cartilage PG loss from explants, compared to normal cartilage. This was completely abrogated by dual AdIGF/AdIL-1Ra transduction, where explant PG content was significantly increased compared to normal cartilage. These data were confirmed by histochemical staining of explants, where PG metachromasia was reduced in normal cartilage exposed to medium from AdIL-1Ra-transduced synoviocytes (Figure 5b ). Cartilage from cultures exposed to IGF-I showed intense PG histochemical staining. Assay of PG in medium from these cultures (Table 3 ) indicated significant PG increase in AdIL-1Ra cultures, and coupled with reduced PG content in these explants, suggested PG depletion by a catabolic agent contained in the medium.
Interleukin-1 conditioning of normal cartilage markedly depleted PG content (Figure 5a ). Comparison of medium PG content showed significant and consistent increases on day 2, when compared to medium from cultures of normal cartilage (Table 3) , supporting active cartilage catabolism. While exposure of IL-depleted explants to medium from AdIGF-I-transduced synoviocyte cultures partly restored PG content in cartilage, AdIGF-I/AdIL-1Ra cotransduction of synoviocytes significantly improved PG content in the cartilage to the point of being statistically comparable to normal cartilage (Figure 5a ). Transduction with IGF-I alone or in combination also tended to reduce PG content in medium on days 4 and 6, confirming active diminution of cartilage degradation. These biochemical findings were supported by toluidine blue histochemical reaction showing intense PG staining with combination IGF-I/IL1Ra therapy (Figure 5b ).
Collagen type II gene expression assessed by in situ localization and quantitative real-time PCR was moderately increased in normal cartilage exposed to AdIGF-I or combination AdIGF-I/AdIL-1Ra (Figure 6a and b) . Collagen type II expression was increased throughout all cartilage layers in these explants exposed to medium containing transgene-derived IGF-I and IGF-I/IL-1Ra. Interleukin-1-conditioned cartilage had moderate increases in collagen type II mRNA expression on in situ hybridization studies, which was enhanced by AdIGF-I and by AdIGF-I/AdIL-1Ra transduction of cocultured synoviocyte monolayers. Quantitative PCR confirmed these trends (Figure 6b ), but only AdIL-1Ra significantly affected collagen type II expression. Serial sections examined by collagen type II immunocytochemistry indicated similar collagen content in control and treated explants, and little obvious differences between normal and IL-1-conditioned cartilage.
Insulin-like growth factor-I ligand distribution in IL-1-conditioned cartilage, assessed by immunohistochemical reaction, showed subjective increases in IGF-I in cocultures where the synoviocytes had been infected with Gene-mediated restoration of IL-1-depleted cartilage AJ Nixon et al AdIGF-I ( Figure 7 ). However, IGF-I staining intensity in cultures infected with AdIL-1Ra was also increased, which suggested that the increased IGF-I content in cartilage may have been the result of mechanisms other than IGF-I autoinduction.
Discussion
Cells of the synovial lining were readily infected with both AdIGF-I and AdIL-1Ra particles. Both transgenes established functional gene expression, which was confirmed to result in synthesis of IGF-I and IL-1Ra by RIA and ELISA, respectively. The functions of this anabolic growth factor and catabolic blocker were most apparent in restoration of PG content of IL-depleted cartilage in AdIGF-I and AdIGF-I/AdIL-1Ra-cotransduced cultures. Insulin-like growth factor-I alone had a partially restorative effect, but a further significant improvement followed dual transduction. These data have several implications, especially given the exposure Figure 2 Interleukin-1 expression in monolayer synoviocyte cultures 6 days after adenoviral transduction with AdIGF-I, AdIL-1Ra, or both AdIGF-I/AdIL-1Ra. Synoviocyte cultures were cocultured with normal or IL-1-depleted cartilage over the 6-day period. Synoviocyte RNA was harvested at the end of the culture period, and gene expression for interleukin-1a (a) or interleukin-1b (b) was assessed by real-time PCR. All data are normalized to copy number of 18S ribosomal RNA. Columns with different statistical letters are significantly different. Gene-mediated restoration of IL-1-depleted cartilage AJ Nixon et al of previously IL-1-depleted cartilage to IL-1Ra. Since IL1Ra has an IL-1 blocking effect by competitive binding to IL-1 cell surface receptors, its putative benefit has been in attenuating active IL-1 downstream signaling. 10, 11 By blocking IL-1 receptor, secreted IL-1Ra has the potential to prevent further cartilage matrix catabolism. Based on partial PG restoration in AdIL-1Ra-exposed explants, IL1Ra had some effect on limiting ongoing degradation, Gene-mediated restoration of IL-1-depleted cartilage AJ Nixon et al high as 115 ng/ml, which is beyond the 100 ng/ml levels generally considered to be maximally stimulatory to chondrocyte anabolic activity. 15, 16 Exposure of synoviocyte monolayer cultures to adenoviral constructs elicited a moderate MMP-3 message response, which was still apparent at the end of the 6 days of coculture. Speculatively, this may have been a cellular response to viral transduction or adenoviral protein synthesis. Despite transduced cultures synthesizing IL-1Ra, IGF-I, or both, synoviocyte MMP-3 expression was uniformly increased, suggesting that the induction of MMP expression was early, before IL-1Ra or IGF-I may have had an opportunity to inhibit this response. Normal untransduced synoviocyte cultures had minimal MMP-3 expression, although coculture with cartilage depleted by IL-1 exposure for 48 h induced mild but detectable MMP-3 expression on Northern blots. There has been little previous attention to viralinduced inflammatory reaction, and this should be viewed as a possible side effect.
Interleukin-1 receptor antagonist protein has shown discrete advantages when evaluated in several in vitro and in vivo experiments. 7, 8, 10, [17] [18] [19] Despite this, culture of normal cartilage in medium containing only IL-1Ra resulted in moderate unexpected PG loss. Examination of the mechanism involved included TaqMan real-time PCR analysis of synoviocyte RNA pools, specifically evaluating IL-1a and IL-1b, TNF-a, and MMP-13 expression. These assays showed moderate increases in IL-1a and b in AdIL-1Ra-transduced synoviocytes. These inducible cytokine fluxes were peculiar to AdIL-1Ra and imply that AdIL-1Ra stimulates expression of IL-1, the action of which it later blocks by receptor antagonism. Secondary increases in MMPs due to this IL-1 production were not apparent. Indeed, MMP 13 message levels were substantially reduced by AdIL-1Ra, and MMP-3 (stromelysin) mRNA expression (on Northern analysis) was similar in all transduced synoviocytes, regardless of transgene construct. These data suggest that MMP-13 is unlikely to play a specific role in IL-1Ra-induced cartilage PG depletion. However, for MMP-3 expression, the AdIL-1Ra treatment group was the only transduced group not to have the anabolic benefit of AdIGF-I in the coculture system, which for AdIL-1Ra/ AdIGF-I and AdIGF-I cultures may have provided the stimulus to PG synthesis to mask any MMP-3-driven catabolic consequences to adenoviral infection. Therefore, AdIL-1Ra transduction alone appeared to result in PG loss, although this probably had little to do with the IL-1Ra component and more to do with the adenovirus infection. There are previous reports of IL-1Ra-induced catabolic activity (Evans CH, personal communication), and the IL-1 response seen in these synoviocyte cultures may help explain this.
The coculture well system was an effective model that partially mimicked the articular environment, providing a large synoviocyte surface area for adenoviral infection of the synovial intimal layers, and subsequent secretion of proteins into the medium that simulated synovial fluid bathing the cartilage surface. Previous studies focus on adenovirus infection of synoviocyte or chondrocyte monolayer cultures, 20 but few compound the effects on cartilage explants by use of coculture well systems. 3, 13 A direct benefit of both AdIGF-I and AdIL-1Ra on cartilage metabolism was then apparent using IL-1-depleted cartilage explants to mimic cartilage from chronically diseased joints. Although osteoarthritis models reveal that many other catabolic mediators are involved in cartilage degradation, IL-1 is a major cytokine in the catabolic crosstalk between synovium and cartilage, [21] [22] [23] [24] [25] [26] [27] and represents a suitable starting point for further in vivo evaluation. The challenge of the immune response to vector delivery of the transgenes potentially may diminish the overall peptide delivery profile, but this information should be derived from animal studies.
The use of PG-depleted cartilage naturally diminishes the likely benefit of IL-1Ra, since the catabolic actions of IL-1 have already occurred. Despite this, enough residual IL-1-driven degradation remained to allow some benefit from AdIL-1Ra transduction alone, and more-so when combined with AdIGF-I cotransduction. These data also indicate that IL-1 exposure may have positive autocrine or paracrine feedback effects on IL-1 expression, as described previously. 28 Further, several papers describe an IGF-I nonresponsive state in OA cartilage, the mechanism of which is still under investigation, but may be due to IL-1 exposure, IGF-binding protein increases, or receptor/signalling attenuation. [29] [30] [31] [32] In the current experiments, responsiveness to IGF-I seemed to be retained, and combinations of IGF-I and IL-1Ra stimulated sufficient PG synthesis over a 6-day period to return the cartilage matrix PG content to normal.
In conclusion, these data suggest that combination gene therapy using growth factors that stimulate cartilage matrix synthesis and IL-1Ra to block IL-1 action have restorative effects on cartilage PG levels. Despite being an IL-1 conditioning chase experiment, the effect of IL-1Ra seemed beneficial, and the combination of IGF-I and IL-1Ra particularly useful in re-establishing cartilage matrix constituents. However, additional benefit to AdIL-1Ra therapy may be revealed by experiments where IL-1Ra is present at the same time as IL-1, perhaps preventing PG depletion, rather than impacting after IL-1 actions had started.
Materials and methods

Adenoviral vector production
Recombinant adenoviral vectors containing either an 888 bp segment of equine IGF-I cDNA (AdIGF-I), or the 534 bp coding region of equine IL-1Ra (AdIL-lRa) were constructed using cre-lox recombination, and propagated in a transformed embryonic kidney cell line, essentially as described by Hardy et al. 33 In each case, the human cytomegalovirus (CMV) early promoter was used to drive transgene expression. This 888 bp IGF-I sequence coded for the entire equine prepropeptide including signal peptide and IGF-IA carboxyl terminal extension peptide as described. 34 Viral particles from lysed cells were purified by banding on two sequential cesium chloride step gradients. Salt was removed by dialysis in a sucrose-containing buffer. Total viral titer of stocks was determined spectrophotometrically, and infectious titer was estimated to be 1% of this total.
Tissue culture Synoviocyte monolayers. Synovial lining from three yearling horses was digested in 0.15%. collagenase and 0.015% DNAseI. Following a 2.5 h digestion at 371C, the Gene-mediated restoration of IL-1-depleted cartilage AJ Nixon et al cells were filtered to remove extracellular debris and centrifuged at 250 g for 10 min. The pellets were washed and cells counted using the supravital dyes fluorescein diacetate and propidium iodide. Synoviocytes were cultured in six-well plates (Corning Inc., Corning, NY, USA) at a density of 1.6 Â 10 5 cells/cm 2 in HEPESbuffered DMEM medium (Gibco-Life Technology, Grand Island, NY, USA) supplemented with 300 mg/ml Lglutamine, 30 mg/ml a-ketoglutarate, and 10% fetal calf serum (FCS). After seeding, the synoviocyte monolayers were rinsed with serum-free medium and (1) maintained as untransduced controls; (2) transduced with AdIGF-I at 200 multiplicities of infection (moi) in a small volume of serum-free DMEM; (3) transduced with AdIL-1Ra at 100 moi; or (4) cotransduced with both AdIGF-I and AdIL1Ra at previous moi. Moi values were based upon spectrophotometric particle counts, and plaque assays verified approximately 1 pfu per 100 particles. Number of infectious particles used was based on previous dose-response studies. 3, 19 All plates were gently agitated for 4 h at 371C. Following viral incubation, monolayers were rinsed and incubated in serum-free DMEM for 48 h.
In proof of principle experiments, synovial monolayer cultures in six-well plates and eight-well chamber slides were maintained for 6 days with medium harvested every 48 h. Total RNA from the six-well plates was harvested using TRIzol solution (Gibco-Life Technologies). Monolayers in eight-well chamber slides were fixed in ice-cold 4% paraformaldehyde for 10 min, then rinsed and stored in PBS at 41C. The medium was harvested from six-well plates and 0.1 volume protease inhibitor solution was added.
Cartilage explant coculture. A second experiment was then performed where synovial monolayers were transduced with AdIGF-I, AdIL-1Ra, or both AdIGF-I and AdIL-1Ra as before, and IL-1 (20 ng/ml for 48 h)-depleted cartilage was exposed to the medium by synovial monolayer/cartilage explant coculture. Cartilage from the femoropatellar joints of horses was trimmed to 4 Â 4 mm explants, pooled, and cultured in 75 cm 2 flasks containing DMEM supplemented with 10% FCS. After 2 days, flasks were split and half cultured in serum-free DMEM medium for 48 h, and the other half were cultured in a similar medium containing 20 ng/ml IL-1a (Genzyme Corp., Framingham, MA, USA). Immediately after synovial cell transduction was complete in six-well plates, coculture well-inserts (Transwell insert, Corning Inc., Corning, NY, USA) were added, and two explants were added to each insert. Wells either contained normal cartilage or cartilage depleted by IL-1 exposure, giving eight different treatment groups with six replicates in each. The medium was harvested every 48 h, and explants and monolayers were harvested after 6 days. Synoviocyte monolayers were harvested for RNA, the edge of explants was removed and fixed for histology, and the remainder of the explant frozen for biochemical and gene expression assays. The fixed sections were paraffin embedded, and sectioned for H&E and toluidine blue staining, in situ localization of IGF-I and type II collagen gene expression, and for identification of IGF-I and collagen type II translated product by immunohistochemistry.
AdIGF-I and AdIL-1Ra transgene expression in synoviocytes Northern analysis. Total RNA (2 mg) per sample from synovial monolayer culture was resolved on a 1.5%. agarose-formaldehyde gel and transferred by capillary blotting to a nylon membrane (Ambion Corp.). The membranes were then probed with radiolabelled IGF-I, IL-1Ra, stromelysin, and elongation factor 1a (EF-1a) cDNAs. Probes included equine-specific IGF-I (880 bp; Genbank accession U85272), equine IL-1Ra (534 bp; Genbank accession U92482), and equine stromelysin (560 bp). 35 The elongation factor 1a (EF-1a) cDNA (provided by Dr Roy Levine, Cornell University) was used to standardize variable RNA loading. 36 Probes were 32 P labelled by random-primed second strand synthesis using a kit (Gibco-Life Technology, Gaithersburg, MD, USA). Blots were washed using standard conditions and autoradiographed on high detail film and screens (BioMax MS, Eastman Kodak, Rochester, NY, USA). Radiographs were scanned, and the pixel intensity of each hybridization product was determined (Adobe PhotoShop 6.0, NIH ImagePCa9 software). Band intensities were normalized by the reciprocal intensity of the EF-1a band from the same sample.
IGF-I and IL-1Ra assays. IGF-I content of media was assessed by radioimmunoassay (RIA) using a competitive binding RIA after acid-ethanol extraction of binding proteins according to the manufacturer's directions (Nichols Institute Diagnostics, San Juan Capistrano, CA, USA). The medium IL-1Ra content was assessed by ELISA according to the manufacturer's directions (R&D Systems, Minneapolis, MN, USA).
Effects of IGF-I and IL-1Ra transgene expression on synoviocytes Taqman real-time PCR. Synoviocyte monolayer RNA was diluted to 5 ng/ml and mixed with prediluted primers and fluorescent probes according to TaqMan s instructions. Gene expression for IL-1a, IL-1b, MMP-13, decorin, and collagen type I were analyzed using TaqMan s Real-Time PCR using the TaqMan s one-step RT-PCR kit (Applied Biosystems, Foster City, CA, USA). Primers and probes were designed from known equine sequences from GenBank using the Primer Express Software (Applied Biosystems) to span exon-exon junction sites for greater binding specificity. The fluorescent-labeled probe has a reporter dye (6-FAM) at the 5 0 end and a quenching dye (TAMRA) at the 3 0 end. Total copy number of mRNA for IL-1a, IL-1b, MMP-13, decorin, and collagen type I was measured from a validated standard curve. Each gene was normalized to 18S RNA expression.
Effects of IGF-I and IL-1Ra transgene expression on cartilage explants Taqman real-time PCR. Gene expression changes in cartilage were assessed by real-time fluorescence PCR. Cartilage RNA was diluted and mixed with prediluted primers and fluorescent probes. Gene expression for collagen type II was analyzed using TaqMan s Real-Time PCR using the one-step RT-PCR kit (Applied Biosystems, Foster City, CA, USA). Primers and probes were designed from known equine sequences from GenBank were prepared for hybridization using a modification of techniques described previously. 3 Equine-specific IGF-I and collagen type II riboprobes were generated from a 208 bp cDNA encoding exons 3 and 5 of equine IGF-IA precursor mRNA, 34 , and a 201 bp coding region of equine collagen type II. Antisense and sense [ 35 S]-UTP (Dupont-NEN)-labeled riboprobes were transcribed on linearized templates. Monolayer slides were hybridized with probe overnight at 431C in a humidified chamber. After incubation, samples were washed in 2 Â SSC/0.5% b-mercaptoethanol at 501C for 15 0 , and in 0.5 Â SSC/ 0.5% b-mercaptoethanol at 501C for 1 h. Samples were then treated with RNaseA (20 mg/ml) in 0.5 M NaCl, 10 mM Tris, pH 7.5, and 5 mM EDTA at 371C, and washed in 2 Â SSC/50% formamide/0.5% b-mercaptoethanol at 451C for 2 h. The slides were dehydrated through a graded series of alcohols containing 300 mM ammonium acetate, dried, and dipped in NTB2 emulsion (Eastman Kodak Co, Rochester, NY USA) and exposed for 14 days. The emulsion was developed in D-19 (Kodak), sections were counterstained with hematoxylin, and examined under bright and dark-field microscopy. All slides were processed in the same batch. Liver, femoral physeal cartilage, and AdIGF-infected chondrocyte monolayers served as positive control tissues for IGF-I, and negative control tissues consisted of skin. Sense-probe was applied to serial chambers or sections from each experimental and control group as a control for nonspecific background hybridization.
Collagen immunohistochemistry. Serial sections were treated with 5 mg/ml hyaluronidase at 371C for 60 min to facilitate antibody penetration into the tissue. Endogenous peroxidases were quenched with 0.5% hydrogen peroxide. Goat serum was applied for 30 min to block nonspecific binding, and rat anti-bovine type II collagen primary antibody (courtesy of Dr Michael Cremer, VA Hospital, Memphis, TN, USA) applied for 60 min. The sections were washed with PBS and the secondary biotinylated goat-anti-rat antibody was applied, followed by streptavidin-conjugated peroxidase to catalyze chromogen development in 3,3 0 -diaminobenzidine tetrachloride. Tissue sections were counter-stained with hematoxylin, and examined by microscopy to determine type II collagen distribution. Control samples for type II were derived from equine costochondral junctions, using the cartilaginous portion as positive and the spongiosa as negative control.
PG assay. The dimethylmethylene blue (DMMB) spectrophotometric assay was used to determine PG content in the medium and cartilage from coculture experiments. This assay used 500 ml of undigested medium or 10 ml of papain-digested cartilage added to 2.5 ml DMMB solution in formate buffer. The optical density was determined at 525 nm. 37 The standard curve was derived from mixed isomer shark chondroitin sulfate.
Statistical analysis
Effects of AdIGF-I and AdIL-1Ra transfections over time were evaluated using ANOVA with appropriate transformations. Least-squares difference or Tukey's multiple comparison analysis was performed to identify significantly different treatments. Significance was set at Po0.05.
